Search Saint Luke's

Saint Luke’s is participating in the ReBIRTH (Randomized Evaluation of Bromocriptine In Myocardial Recovery Therapy) clinical trial to help develop more effective treatments for peripartum cardiomyopathy.

Recognize a team members commitment to care by nominating them for a DAISY, BEE, or Sunshine Award.

Heart Failure 
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients (REDEFINE-HF)

Our doctors, nurses, and staff are committed to working with referring physicians to provide your patients the highest level of care, ensuring the best possible outcomes. Our teams are:

Urinary incontinence affects millions of women, and many believe it’s something they just must live with. It’s not.

Heart Failure 
RELIVE Trial- Randomized Evaluation of Less Invasive Ventricular Enhancement

Fifteen years ago, while living in New York, Kenneth Sondermeyer started having increasing shortness of breath. Maybe it was asthma, he thought. He went to his primary care provider, who sent him to see a cardiologist.

Please fill in the fields below to receive more information on Saint Luke’s Mid America Heart Institute.

This form is to be completed in connection with the Saint Luke’s Health System Policy on Conflicts of Interest in Research, RES-052, by all Investigators responsible for Sponsored Research activities, regardless of title or position, who are responsible for the design, conduct, or reporting of Research or proposals for funding of Research. Potential conflicts may be related to Conflicts of Commitment or Financial Interests, as defined by the policy.

New scientific paper proposes SGLT inhibitors as a therapy to slow aging at the cellular level and improve longevity.